ArticleNature communications2021

Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.

Baotong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.